Media: Norwegian investors may lose nearly EUR 28m off investments in a UK biotech company

Salamander Invest has been the main financier of UK-based biotech company Fortuna Fix, which the High Court of Justice in London placed under administration in January. Currently, around NOK 300m (EUR 28m) is being invested in a firm, and more investments would be needed to keep the research going.

Stein Erik Hagen is one of Norway's richest persons. Photo: Casper Dalhoff/KULTUR

Log in to read our articles

Welcome to AMWatch. A part of our content is exclusive and reserved for our users.

Try AMWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles

amwatch trial

Latest news


See all

See all

Latest news from FinansWatch (dk)

Latest news from EnergyWatch

Latest news from ShippingWatch